Safety and effectiveness of regorafenib in recurrent HCC after liver transplantation and progression on sorafenib: A real-life multicentre study

被引:0
|
作者
Lavarone, Massimo [1 ]
Invernizzi, Federica [1 ]
Czauderna, Carolin [2 ]
Sanduzzi Zamparelli, Marco [3 ]
Bhoori, Sherrie [4 ]
Amaddeo, Giuliana [5 ]
Manini, Matteo Angelo [6 ]
Fraile, Miguel [7 ]
Margarita Anders, Maria [8 ]
Pinter, Matthias [9 ]
Blanco Rodriguez, Maria Jose [10 ]
Romero, Mario [11 ]
Gabriel Alejandro, Aballay Soteras [12 ]
Pinero, Federico [13 ]
Villadsen, Gerda Elisabeth [14 ]
Weinmann, Arndt [2 ]
Crespo, Gonzalo [15 ]
Mazzaferro, Vincenzo [16 ,17 ]
Regnault, Helene [5 ]
De Giorgio, Massimo [6 ]
Gonzalez Dieguez, Maria Luisa [7 ]
Donato, Maria Francesca [1 ]
Varela, Maria [7 ]
Marcus, Worns [2 ]
Bruix, Jordi [3 ]
Lampertico, Pietro [1 ]
Reig, Maria [3 ]
机构
[1] Univ Milan, Div Gastroenterol & Hepatol, CRCAM & A Migliavacca Ctr Liver Dis, Fdn IRCCS Ca Granda Maggiore Hosp, Milan, Italy
[2] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Internal Med 1, Mainz, Germany
[3] Univ Barcelona, Hosp Clin, Barcelona Clin Liver Canc BCLC Grp, IDIBAPS,Liver Unit,CIBERehd, Barcelona, Spain
[4] Fdn IRCCS Ist Nazl Tumori, GI Surg & Liver Trasplantat Unit, Milan, Italy
[5] Hop Henri Mondor, INSERM, U955, Serv Hepatol,Equipe 18,Virus Immunite Canc, Creteil, France
[6] Azienda Socio Sanitaria Terr ASST Papa Giovanni X, Gastroenterol Hepatol & Transplant Unit, Dept Specialty & Transplant Med, Bergamo, Italy
[7] Hosp Univ Cent Asturias, Liver Unit, Oviedo, Spain
[8] Hosp Aleman, Unidad Hepatol & Trasplante Hepat, Buenos Aires, DF, Argentina
[9] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria
[10] Hosp Jerez, Jerez de la Frontera, Spain
[11] Gregorio Maranon Hosp, Liver Dept, Madrid, Spain
[12] Sanatorio Trinidad Mitre, Caba, Argentina
[13] Hosp Univ Austral, Sch Med, Buenos Aires, DF, Argentina
[14] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus C, Denmark
[15] Univ Barcelona, Liver Transplant Unit, Liver Unit, Hosp Clin,IDIBAPS,CIBERehd, Barcelona, Spain
[16] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[17] Univ Milan, GI Surg & Liver Trasplantat Unit, Milan, Italy
关键词
D O I
10.1016/S0618-8278(19)31209-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
FRI-473
引用
收藏
页码:E606 / E607
页数:2
相关论文
共 50 条
  • [21] Safety and Feasibility of Using Sorafenib in Recurrent Hepatocellular Carcinoma after Orthotopic Liver Transplantation
    Kim, Richard
    El-Gazzaz, Galal
    Tan, Ann
    Elson, Paul
    Byrne, Michael
    Chang, Young Doo
    Aucejo, Federico
    ONCOLOGY, 2010, 79 (1-2) : 62 - 66
  • [22] Efficacy and safety of rituximab in myasthenia gravis: a French multicentre real-life study
    Dos Santos, A.
    Noury, J. -B.
    Genestet, S.
    Nadaj-Pakleza, A.
    Cassereau, J.
    Baron, C.
    Videt, D.
    Michel, L.
    Pereon, Y.
    Wiertlewski, S.
    Magot, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (11) : 2277 - 2285
  • [23] A 52-week update of a multicentre real-life experience on effectiveness and safety of risankizumab in psoriasis
    Hansel, K.
    Zangrilli, A.
    Bianchi, L.
    Peris, K.
    Chiricozzi, A.
    Offidani, A.
    Diotallevi, F.
    Fargnoli, M. C.
    Esposito, M.
    Amerio, P.
    Gualdi, G.
    Bianchi, L.
    Stingeni, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (02) : E111 - E113
  • [24] Real-life experience with mTOR inhibitors treatment after liver transplantation
    Gilad, O.
    Rabinowich, L.
    Gotlieb, N.
    Katz, P.
    Lubezky, N.
    Shibolet, O.
    Katchman, H.
    TRANSPLANTATION, 2019, 103 (08) : 298 - 298
  • [25] Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study
    Ruaro, Barbara
    Salotti, Andrea
    Reccardini, Nicolo
    Kette, Stefano
    Da Re, Beatrice
    Nicolosi, Salvatore
    Zuccon, Umberto
    Confalonieri, Marco
    Mondini, Lucrezia
    Pozzan, Riccardo
    Hughes, Michael
    Confalonieri, Paola
    Salton, Francesco
    PHARMACEUTICALS, 2024, 17 (01)
  • [26] Real-life effectiveness and safety of ABP501, an adalimumab biosimilar, in inflammatory bowel disease: a multicentre Italian study
    Barberio, B.
    Zingone, F.
    Ferronato, A.
    Buda, A.
    Melatti, P.
    Gubbiotti, A.
    Massimi, D.
    Casadei, C.
    Cingolani, L.
    Savarino, E. V.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S397 - S397
  • [27] Regorafenib improves survival after sorafenib treatment in patients with recurrent hepatocellular carcinoma after liver transplantation, compared to best supportive care
    Iavarone, Massimo
    Invernizzi, Federica
    Zavaglia, Claudio
    Sanduzzi Zamparelli, Marco
    Fraile, Miguel
    Czauderna, Carolin
    Di Costanzo, Giuseppe
    Bhoori, Sherrie
    Pinter, Matthias
    Manini, Matteo Angelo
    Amaddeo, Giuliana
    Fernandez, Ainhoa
    Pinero, Federico
    Blanco Rodriguez, Maria Jose
    Anders, Maria Margarita
    Aballay Soteras, Gabriel Alejandro
    Villadsen, Gerda Elisabeth
    Cesarini, Lucia
    Mazza, Stefano
    Diaz-Gonzalez, Alvaro
    Gonzalez Dieguez, Maria Luisa
    Tortora, Raffaella
    Weinmann, Arndt
    Mazzaferro, Vincenzo
    Romero, Mario
    Crespo, Gonzalo
    Regnault, Helene
    De Giorgio, Massimo
    Varela, Maria
    Donato, Maria Francesca
    Worns, Marcus-Alexander
    Bruix, Jordi
    Lampertico, Pietro
    Reig, Maria
    JOURNAL OF HEPATOLOGY, 2020, 73 : S103 - S104
  • [28] LEDIPASVIR/SOFOSBUVIR FOR RECURRENT HEPATITIS C IN LIVER TRANSPLANT RECIPIENTS: A REAL-LIFE SPANISH MULTICENTRE EXPERIENCE
    Prieto, M.
    Fernandez, I.
    Londono, M. -C.
    Abradelo, M.
    Pascasio, J. M.
    Gea, F.
    Rincon, D.
    Cuervas-Mons, V.
    Crespo, G.
    Montero, J. L.
    Hontangas, V.
    Baliellas, C.
    Sousa, J. M.
    Garcia, M.
    Pascual, S.
    Pons, J. A.
    Castells, L.
    Testillano, M.
    Jimenez, M.
    Otero, A.
    Molina, E.
    Gonzalez, A.
    Nogueras, F.
    Gonzalez-Dieguez, L.
    Lorente, S.
    Sanchez-Antolin, G.
    Herrero, J. I.
    Casafont, F.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S794 - S795
  • [29] Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study
    Guidelli, G. M.
    Viapiana, O.
    Luciano, N.
    De Santis, M.
    Boffini, N.
    Quartuccio, L.
    Birra, D.
    Conticini, E.
    Chimenti, M. S.
    Bazzani, C.
    Bruschi, E.
    Riva, M.
    Canziani, L. M.
    Bianchi, G.
    Pozzi, M. R.
    Limonta, M.
    Gorla, R.
    Perricone, R.
    Frediani, B.
    Moscato, P.
    De Vita, S.
    Dagna, L.
    Rossini, M.
    Selmi, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (04) : 868 - 873
  • [30] ONE-YEAR EFFECTIVENESS, RETENTION RATE AND SAFETY OF SECUKINUMAB IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: A REAL-LIFE MULTICENTRE STUDY
    Chimenti, M. S.
    Fonti, G. L.
    Conigliaro, P.
    Sunzini, F.
    Scrivo, R.
    Navarini, L.
    Triggianese, P.
    Peluso, G.
    Scolieri, P.
    Caccavale, R.
    Picchianti-Diamanti, A.
    De Martino, E.
    Salemi, S.
    Birra, D.
    Altobelli, A.
    Paroli, M.
    Bruzzese, V.
    Lagana, B.
    Gremese, E.
    Conti, F.
    Afeltra, A.
    Perricone, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 716 - 716